Exercise dose and threshold for adverse outcome in arrhythmogenic cardiomyopathy

Back

ESC Premium Access

Exercise dose and threshold for adverse outcome in arrhythmogenic cardiomyopathy

Session: Cardiomyopathies: new insights

Topic: Cardiomyopathies

Speaker: Doctor O. Lie (Oslo, NO)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Oyvind H Lie

Oslo University Hospital Rikshospitalet, Oslo (Norway)

1 presentation

0 follower

8 more presentations in this session

Immune-mediated myocardial inflammation in Fabry Disease cardiomyopathy

Speaker: Doctor A. Frustaci (Rome, IT)

Access

Abstract

Takotsubo cardiomyopathy complicated by cardiogenic shock. Insights from the nationwide RETAKO Registry

Speaker: Doctor M. Almendro (Seville, ES)

Discordance between the criteria for ICD implantation in the primary prevention of sudden death among patients with hypertrophic cardiomyopathy

Speaker: Doctor P. Freitas (Carnaxide, PT)

Cardiac transplantation in hypertrophic cardiomyopathy in the united states: 2003-2011.

Speaker: Doctor J. Shirani (Bethlehem, US)

Cardiac sarcoidosis may meet the diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy

Speaker: Doctor P. Simonen (Helsinki, FI)

Access the full session

Cardiomyopathies: new insights

Speakers: Doctor O. Lie, Doctor A. Frustaci, Doctor M. Almendro, Doctor P. Freitas, Doctor J. Shirani...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources